Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Novel Markers for Improved Diagnosis of Rheumatoid Arthritis

06.09.2012
</a><strong>Background</strong><br>

Rheumatic diseases are the most common chronic inflammatory disorders. Approximately 1 out of 100 humans in western European countries suffers from rheumatoid arthritis (RA). Since only the early treatment allows keeping the disease progression under control, an improved diagnosis is needed, that unequivocally distinguish RA from other arthritis features. Rheumatoid factor (RF) traditionally has been the standard serological test, but its poor specificity and sensitivity limit its usefulness. The combined use of RFs with the anti-cyclic citrullinated peptide (anti-CCP) or assays resulted in detection levels of about 40% of early arthritis patients and 70-80% of established RA patients.<br><br> <strong>Technology</strong><br> Therefore the present invention provides a tool with strong diagnostic perfor-mance, including high specificity, high sensitivity, and a high prognostic value: The combination of peptides, derived from a set of heterogenous nuclear ribonucleoproteins (hnRNPs) can predict over 94% of established RA patients and also over 78 % of patients with systemic lupus erythematosus (SLE). <br><br>

<b>Benefits:</b><ul> <li>Novel polypeptides for detecting RA-associated autoantibodies, that allow for an improved diagnosis of RA (94%) and SLE (78%).</li> <li>Peptides of the invention turned out to be particularly useful in diag-nosis of RA with an erosive course of the disease.</li> <li>Specific reactivity with antibodies in or isolated from body fluids of RA-patients (e.g. blood, tears, synovial fluid, plasma, urine).</li> <li>The diagnostic assay can be of any type, such as ELISA, Luminex bead arrays and strip arrays etc</li> </ul> <p><strong>IP Rights</strong><br> EP-Priority (12/2008)<br> PCT Application (12/2009) <br><br> <strong>Patent Owner</strong><br> Charité-Universitätsmedizin Berlin<br> in.vent Diagnostica GmbH

Further Information: PDF

ipal GmbH
Phone: +49 (0)30/2125-4820

Contact
Dr. Dirk Dantz

info@technologieallianz.de | TechnologieAllianz e.V.
Further information:
http://www.technologieallianz.de/angebote.php?sort=sag&id=1582&lang=en
http://www.technologieallianz.de

More articles from Technology Offerings:

nachricht New Lithium Salts of Pentafluorophenylamide Anions as Electrolytes in Lithium Ionic Batteries
18.04.2017 | TechnologieAllianz e.V.

nachricht Gratings on glass surfaces
28.03.2017 | TechnologieAllianz e.V.

All articles from Technology Offerings >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Ultrafast snapshots of relaxing electrons in solids

Using ultrafast flashes of laser and x-ray radiation, scientists at the Max Planck Institute of Quantum Optics (Garching, Germany) took snapshots of the briefest electron motion inside a solid material to date. The electron motion lasted only 750 billionths of the billionth of a second before it fainted, setting a new record of human capability to capture ultrafast processes inside solids!

When x-rays shine onto solid materials or large molecules, an electron is pushed away from its original place near the nucleus of the atom, leaving a hole...

Im Focus: Quantum Sensors Decipher Magnetic Ordering in a New Semiconducting Material

For the first time, physicists have successfully imaged spiral magnetic ordering in a multiferroic material. These materials are considered highly promising candidates for future data storage media. The researchers were able to prove their findings using unique quantum sensors that were developed at Basel University and that can analyze electromagnetic fields on the nanometer scale. The results – obtained by scientists from the University of Basel’s Department of Physics, the Swiss Nanoscience Institute, the University of Montpellier and several laboratories from University Paris-Saclay – were recently published in the journal Nature.

Multiferroics are materials that simultaneously react to electric and magnetic fields. These two properties are rarely found together, and their combined...

Im Focus: Fast, convenient & standardized: New lab innovation for automated tissue engineering & drug

MBM ScienceBridge GmbH successfully negotiated a license agreement between University Medical Center Göttingen (UMG) and the biotech company Tissue Systems Holding GmbH about commercial use of a multi-well tissue plate for automated and reliable tissue engineering & drug testing.

MBM ScienceBridge GmbH successfully negotiated a license agreement between University Medical Center Göttingen (UMG) and the biotech company Tissue Systems...

Im Focus: Silencing bacteria

HZI researchers pave the way for new agents that render hospital pathogens mute

Pathogenic bacteria are becoming resistant to common antibiotics to an ever increasing degree. One of the most difficult germs is Pseudomonas aeruginosa, a...

Im Focus: Artificial Enzymes for Hydrogen Conversion

Scientists from the MPI for Chemical Energy Conversion report in the first issue of the new journal JOULE.

Cell Press has just released the first issue of Joule, a new journal dedicated to sustainable energy research. In this issue James Birrell, Olaf Rüdiger,...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

“Lasers in Composites Symposium” in Aachen – from Science to Application

19.09.2017 | Event News

I-ESA 2018 – Call for Papers

12.09.2017 | Event News

EMBO at Basel Life, a new conference on current and emerging life science research

06.09.2017 | Event News

 
Latest News

“Lasers in Composites Symposium” in Aachen – from Science to Application

19.09.2017 | Event News

New quantum phenomena in graphene superlattices

19.09.2017 | Physics and Astronomy

A simple additive to improve film quality

19.09.2017 | Power and Electrical Engineering

VideoLinks
B2B-VideoLinks
More VideoLinks >>>